 ROSCREA, Ireland, Jan. 10, 2023 PRNewswire Renexxion Ireland Limited Renexxion, a private biopharmaceutical company committed to delivering innovative drugs to patients with high unmet need in gastrointestinal GI disorders, is pleased to announce opening of the Investigational New Drug IND application with the U.S Food and Drug Administration FDA for naronapride for the treatment... The post Renexxion Announces Opening of Investigational New Drug IND Application for Naronapride for... 